Surgery Partners, Inc. (SGRY)
Stock Price Chart
Key Info
| Market Cap | 1.00B |
| Revenue (ttm) | 1.78B |
| Net Income (ttm) | -94.90M |
| Shares Out | 50.52M |
| EPS (ttm) | -2.73 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
Stock Quote
| Trading Day | Aug 7, 2020 |
| Last Price | $19.85 |
| Previous Close | $20.19 |
| Change ($) | -0.34 |
| Change (%) | -1.68% |
| Day's Open | 20.00 |
| Day's Range | 19.35 - 20.96 |
| Day's Volume | 487,248 |
| 52-Week Range | 4.00 - 20.96 |
More Stats
| Market Cap | 1.00B |
| Enterprise Value | 3.66B |
| Earnings Date (est) | Nov 4, 2020 |
| Ex-Dividend Date | n/a |
| Shares Outstanding | 50.52M |
| Float | 20.16M |
| EPS (basic) | -2.72 |
| EPS (diluted) | -2.73 |
| FCF / Share | 4.58 |
| Dividend | n/a |
| Dividend Yield | n/a |
| Earnings Yield | n/a |
| FCF Yield | 22.29% |
| Payout Ratio | n/a |
| Shares Short | 3.32M |
| Short Ratio | 6.13 |
| Short % of Float | 16.30% |
| Beta | 3.50 |
| PE Ratio | n/a |
| Forward PE | n/a |
| P/FCF Ratio | 4.49 |
| PS Ratio | 0.56 |
| PB Ratio | 1.22 |
| Revenue | 1.78B |
| Operating Income | 188.50M |
| Net Income | -94.90M |
| Free Cash Flow | 223.50M |
| Net Cash | -2.66B |
| Net Cash / Share | -52.63 |
| Gross Margin | 23.74% |
| Operating Margin | 10.56% |
| Profit Margin | -7.40% |
| FCF Margin | 12.52% |
| ROA | 2.29% |
| ROE | 1.26% |
| ROIC | 2.20% |
Analyst Summary
Analyst Consensus: Buy
Financial Performance
Financial Overview
| Year | 2019 | 2018 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|
| Revenue | 1,831 | 1,772 | 1,145 | 960 | 403 | 285 |
| Revenue Growth | 3.38% | 54.66% | 19.33% | 138.02% | 41.7% | - |
| Gross Profit | 424 | 410 | 324 | 291 | 149 | 115 |
| Operating Income | 237 | 68.90 | 204 | 157 | 72.96 | 68.09 |
| Net Income | -74.80 | -206 | 9.45 | 1.43 | -65.90 | -9.06 |
| Shares Outstanding | 48.28 | 48.03 | 48.02 | 36.07 | 32.30 | 31.82 |
| Earnings Per Share | -2.29 | -4.96 | 0.20 | 0.04 | -2.04 | -0.28 |
| EPS Growth | - | - | 400% | - | - | - |
| Operating Cash Flow | 130 | 145 | 125 | 84.48 | 21.95 | 49.08 |
| Capital Expenditures | -73.60 | -39.80 | -39.11 | -33.44 | -7.74 | -4.15 |
| Free Cash Flow | 55.90 | 105 | 86.13 | 51.04 | 14.21 | 44.93 |
| Cash & Equivalents | 92.70 | 184 | 80.57 | 71.92 | 74.92 | 0.00 |
| Total Debt | 2,864 | 2,327 | 1,442 | 1,255 | 1,361 | - |
| Net Cash / Debt | -2,771 | -2,142 | -1,362 | -1,183 | -1,286 | 0.00 |
| Assets | 5,019 | 4,676 | 2,305 | 2,104 | 1,859 | - |
| Liabilities | 4,036 | 3,577 | 1,980 | 1,807 | 1,829 | - |
| Book Value | 297 | 405 | 9.68 | -4.03 | -264 | - |
Company Profile
Company Details
| Full Name | Surgery Partners, Inc. |
| Country | United States |
| Employees | 6,900 |
| CEO | J. Eric Evans |
Stock Information
| Ticker Symbol | SGRY |
| Stock Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Unique Identifier | NASDAQ: SGRY |
| IPO Date | October 1, 2015 |
Description
Surgery Partners, Inc., through its subsidiaries, owns and operates a network of surgical facilities and related services in the United States. The company operates through three segments: Surgical Facility Services, Ancillary Services, and Optical Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The company's surgical hospitals also provide ancillary services, such as diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care; and ancillary services, which consist of a diagnostic laboratory, multi-specialty physician practices, urgent care facilities, anesthesia services, and optical services. It also operates optical laboratory that manufactures eyewear. As of March 31, 2020, the company owned or operated a portfolio of 127 surgical facilities, including 111 ambulatory surgical centers and 16 surgical hospitals in 30 states. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.